Finland: Nordstjernan acquires diagnostics company Aidian from Axcel

Aidian LF SARS CoV-2 kit

Swedish investment company Nordstjernan has agreed to acquire Finnish in-vitro diagnostics company, Aidian, from funds managed by the Nordic PE firm Axcel. Aidian is a global provider of instruments and tests within the growing point-of-care market. Its diagnostic tests facilitate the tackling of health threats, including antimicrobial resistance, diabetes and colorectal cancer. The company was…

You must be a HMI Subscriber to view this content.

Subscribe Now »